Neoadjuvant Chemo-Immunotherapy: Clinical Trials

4 trials of Neoadjuvant Chemo-Immunotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 2 recruiting. 3 Phase 2, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 2, Not yet recruiting 1
Not applicable1Not yet recruiting 1
Phase 11Recruiting 1

Follow Neoadjuvant Chemo-Immunotherapy: new trials by email Literature Review of Neoadjuvant Chemo-Immunotherapy trials Research Report on Neoadjuvant Chemo-Immunotherapy

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal Carcinoma
Neoadjuvant Chemo-Immunotherapy - Locally Advanced Sinonasal Carcinoma
Phase 2Not yet recruitingSun Yat-sen University232026-07-312026-06-25
Pucotenlimab Combined With Chemotherapy as Perioperative Treatment for Locally Advanced Gastroesophageal Junction Carcinoma
Neoadjuvant chemo-immunotherapy - Gastroesophageal Junction, Gastric / Gastroesophageal Junction Adenocarcinoma
Not applicableNot yet recruitingTang-Du Hospital302025-08-012025-07-29
NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study
Neoadjuvant chemo-immunotherapy, Extended pleurectomy/decortication in case of reaching operability - Pleural Epithelioid Mesothelioma, Mesothelioma; Pleura
Phase 1 / Phase 2RecruitingUniversity Hospital, Antwerp372025-07-222025-08-13
Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy
Neoadjuvant chemo-immunotherapy, Bevacizumab, Radiotherapy - Stage III Non-small Cell Lung Cancer
Phase 2RecruitingSun Yat-sen University1162022-01-012024-10-30

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Mesothelioma, Malignant (1)

Sponsors

Sun Yat-sen University (2)  ·  Tang-Du Hospital (1)  ·  University Hospital, Antwerp (1)

Countries

Belgium (1)  ·  China (1)

Top investigators

Chunyan Chen (1)  ·  Hui Liu (1)  ·  Xuekui Liu (1)

Results publications

PMID 20980108, PMID 28885881, PMID 29658848, PMID 32424483, PMID 32979984, PMID 32997907

NIH funding

2023 (1)